Michael Jay, PhD
Research Interests
My research projects are centered on the interface between the pharmaceutical and nuclear sciences. They involve the application of pharmaceutical approaches to solve problems related to nuclear imaging and therapy, and the use of radioanalytical approaches to solve problems encountered in the development of novel formulations and drug delivery systems. I am also involved in patent and entrepreneurial activities, and am the co-founder of two start-up companies, Cherry Orchard Products LLC and Capture Pharmaceuticals Inc.
Research Projects
- Orally Bioavailable Prodrugs of DTPA as Radionuclide Decorporation Agents
- Dual Therapeutic/Imaging Nanovectors for Assessing Enhanced Anti‐Tumor Activity of Chemotherapeutic Agents
